Optimizing pharmacologic thromboprophylaxis in medical inpatients using sequential IMPROVE risk assessment models: Clinical, economic and environmental implications

Vascular Diseases · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles